SIC 2834 – Pharmaceutical Preparations
| Valuation | |
|---|---|
| Market Cap ($M) | 1,494.45 |
| Enterprise Value ($M) | 1,566.87 |
| Book Value ($M) | 622.07 |
| Book Value / Share | 4.75 |
| Price / Book | 2.40 |
| NCAV ($M) | 484.10 |
| NCAV / Share | 3.70 |
| Price / NCAV | 3.09 |
| Profitability (mra) | |
|---|---|
| Return on Invested Capital (ROIC) | -0.01 |
| Return on Assets (ROA) | -0.01 |
| Return on Equity (ROE) | -0.01 |
| Liquidity (mrq) | |
|---|---|
| Quick Ratio | 12.96 |
| Current Ratio | 13.81 |
| Balance Sheet (mrq) ($M) | |
|---|---|
| Current Assets | 859.12 |
| Assets | 997.10 |
| Liabilities | 375.02 |
| Debt | n/a |
| Equity | n/a |
| Income Statement (mra) ($M) | |
|---|---|
| Revenue | 232.28 |
| Operating Income | -30.45 |
| Net Income | -6.39 |
| Earnings Per Share Basic And Diluted | n/a |
| Cash Flow Statement (mra) ($M) | |
|---|---|
| Cash From Operations | 100.56 |
| Cash from Investing | -153.93 |
| Cash from Financing | 1.39 |
(click for more detail) |
|
| File Date | Form | Activist 13D/G Investors | Ownership (%) |
Change (%) |
|---|---|---|---|---|
| 13G/A | Deep Track Capital, LP | 5.49 | 8.19 | |
| 13G/A | Vanguard Group Inc | 7.18 | 11.16 | |
| 13G/A | State Street Corp | 7.35 | -4.97 | |
| 13G/A | BlackRock Inc. | 18.10 | 22.58 | |
| 13G/A | Federated Hermes, Inc. | 8.79 | -10.09 |
| Top 13F Investors | Shares (1000) |
Change (%) |
Value ($1000) |
Change (%) |
|---|---|---|---|---|
(click for more detail) |
||||
| Date | Insider Trades | Code | Shares | Value |
|---|---|---|---|---|
(click for more detail) |
||||
| File Date | Form | SEC Filings |
|---|---|---|
| UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 10-K | ||
| UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 10-Q | ||
| UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 10-Q | ||
| UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 10-Q | ||
(click for more detail) |
||
| Short Volume | |||
|---|---|---|---|
| Market Date | Short Volume | Total Volume | Short Volume Ratio |
| 474,908 | 1,433,628 | 33.13 | |
| 159,250 | 820,817 | 19.40 | |
| 157,719 | 599,788 | 26.30 | |
| 179,294 | 1,121,416 | 15.99 | |
(click for more detail) |
|||
| Similar Companies | |
|---|---|
| DCPH – Deciphera Pharmaceuticals, Inc. | DNLI – Denali Therapeutics Inc. |
| DSGN – Design Therapeutics, Inc. | EDIT – Editas Medicine, Inc. |
| ELEV – Elevation Oncology, Inc. |